technologies that allow the efficient chemical modification of proteins under mild conditions are widely sought after. sortasemediated peptide ligation provides a strategy for modifying the n or c terminus of proteins. this protocol describes the use of depsipeptide substrates (containing an ester linkage) with sortase a (srta) to completely modify proteins carrying a single n-terminal glycine residue under mild conditions in 4-6 h. the srta-mediated ligation reaction is reversible, so most labeling protocols that use this enzyme require a large excess of both substrate and sortase to produce high yields of ligation product. In contrast, switching to depsipeptide substrates effectively renders the reaction irreversible, allowing complete labeling of proteins with a small excess of substrate and catalytic quantities of sortase. Herein we describe the synthesis of depsipeptide substrates that contain an ester linkage between a threonine and glycolic acid residue and an n-terminal FItc fluorophore appended via a thiourea linkage. the synthesis of the depsipeptide substrate typically takes 2-3 d.
IntroDuctIon
Chemical modification of proteins is widely used to optimize the properties of biopharmaceuticals; it also provides chemical biologists with powerful strategies to study the molecular basis for life. It is essential that protein modification strategies are robust and efficient. Common strategies include alkyne-azide cycloadditions 1,2 , Staudinger ligation 3, 4 and maleimide conjugation. However, all these strategies have associated challenges and limitations, for example, the necessity to incorporate non-natural amino acid residues into the protein to be labeled 5 , the nontrivial synthesis of labeling reagents, the risk of nonspecific modification to the protein 6 and, typically, a requirement for a large excess of reagents to ensure successful couplings. Here we report an optimized protocol that uses sortase and depsipeptide substrates to allow the efficient modification of proteins.
Sortases are a class of transpeptidase enzymes that are responsible for 'sorting' and covalently anchoring virulence factors to the cell wall of Gram-positive bacteria 7, 8 . Sortase A (SrtA) is a type II membrane protein, native to Staphylococcus aureus, that ligates proteins carrying an LPXTG recognition motif to peptidoglycan substrates harboring an N-terminal oligoglycine sequence 9 . The catalytic cysteine residue located in the active site of SrtA cleaves the amide bond between the threonine and glycine residues of the LPXTG substrate to form a thioacylenzyme intermediate 10 . The intermediate is then attacked by the oligoglycine substrate to form a new ligated product.
The advantage of using SrtA as a tool for protein modification became apparent once the catalytic core of the enzyme had been heterologously expressed nearly 15 years ago 7, 9 . Since then the enzyme has been used extensively to modify proteins at both the N and C termini with a large variety of different labels 11, 12 , including biotin 13 , glycosylphosphatidylinositol (GPI) mimics 14 , fluorescent tags 13 , PEG chains 15 and other biologically important molecules 16, 17 . The vast majority of examples of sortase-mediated ligation have used synthetic N-terminal oligoglycine peptides to label proteins harboring a flexible C-terminal LPXTG motif. Alternatively, this approach can be reversed to allow the modification of proteins carrying an N-terminal oligoglycine sequence under the same mild conditions 18, 19 . However, as the ligation reaction is reversible, a large excess of labeling reagent is normally required to achieve high levels of protein modification, which may not always be desirable or possible. The reaction can be rendered effectively irreversible if the scissile peptide bond (i.e., the amide bond between the threonine and glycine residues) is replaced by an ester linkage (Fig. 1a) 20 . In this regard, a methyl ester of the desired peptide can be used as a substrate for the N-terminal protein ligation; however, a high concentration of SrtA and a large excess of methyl ester labeling reagent are required to achieve a high ligation yield.
In our laboratory, we have found that depsipeptide substrates can provide a more efficient approach to achieve quantitative labeling of proteins carrying a single N-terminal glycine residue (Fig. 1b) 21 . The efficiency of the SrtA-mediated ligation reaction is markedly improved when using depsipeptide substrates such that typically only 1.5-3 molar equivalents of the label and 0.1-0.2 molar equivalents of SrtA are required to completely modify proteins. Conversely, protocols for N-terminal labeling with unmodified peptides stipulate 20-50 equivalents of peptides and 2-3 equivalents of SrtA 22 . If the label is precious and/or is difficult to acquire, this ability to maximize the yield of protein modification is highly desirable.
The advantages and limitations of using standard and depsipeptide substrates are summarized in Table 1 .
Synthesis of the depsipeptide amino acid
The protected depsipeptide amino acid is synthesized in two solution-phase steps in high yield ( Fig. 2) : alkylation of a commercially available Fmoc-threonine derivative and a subsequent hydrogenolysis of the C-terminal benzyl ester group. Although both synthetic steps are relatively simple, the hydrogenolysis of the benzyl protecting group requires careful monitoring. The resulting depsipeptide amino acid can be incorporated into a growing peptide chain by using standard solid-phase peptide synthesis (SPPS) methodologies to produce depsipeptide substrates for SrtA (Fig. 2) . Resins having 2-chlorotrityl or Rink amide linkers both provide high yields of depsipeptides 21 .
We describe the synthesis on a 10-g scale, but there is no practical reason why this could not be scaled up or down by a factor of 2-5. The reaction thermodynamics have not, however, been thoroughly investigated, so we would not recommend that nonspecialists attempt larger-scale reactions.
This synthetic strategy could feasibly be used to link any commercially available Fmoc-protected amino acid with glycolic acid to form a range of depsipeptide substrates. This was first demonstrated by Suich et al. 23 to make an Fmoc-Tyr(OtBu)-Gc-OH amino acid. Replacement of the glycine-mimicking analog, glycolic acid, is also feasible but would be dependent on the availability of suitably protected enantiomerically enriched α-bromoalkanoic acids.
Depsipeptide incorporation into the peptide
The use of SPPS to prepare the depsipeptide substrate enables easy incorporation of a wide range of labels (e.g., fluorophores, affinity tags and bioorthogonal reactive groups), and, in general, the resulting structures are limited only by the availability of SPPS-compatible building blocks. The depsipeptide substrates can then be used directly to transform proteins carrying an N-terminal glycine residue under mild aqueous conditions within 4-6 h.
Protein labeling
Although only one glycine residue is necessary for ligation to occur successfully, it is essential that the glycine residue is sterically unhindered; typically a spacer of three or four amino acid residues from a globular domain is sufficient to allow ligation to occur. Although a competing hydrolysis reaction may occur upon extended incubation with sortase, high ligation yields can usually be achieved with substrate protein concentrations >50 µM and 1.5-3 equivalents of the depsipeptide label. Incorporation of an N-terminal glycine residue into a protein can be achieved in a number of different ways. For example, proteins are always expressed with either a methionine or an N-formylmethionine at their N terminus, which is usually removed in vivo. In principle, a given protein's gene sequence could be modified to incorporate a glycine as the second N-terminal amino acid, which would be exposed after the methionine is lost. Alternatively, periplasmic targeting sequences can be designed to leave an N-terminal glycine residue once the sequence has been removed during cotranslational protein export into the periplasm 24 . A third in vitro approach would be to engineer a suitable protease (e.g., tobacco etch virus (TEV) or Factor Xa) recognition sequence immediately before a glycine residue that would allow the release of a protein carrying an N-terminal glycine residue once the cleavage event has taken place. In this protocol, we describe detailed conditions for the synthesis of the required depsipeptide building block, the synthesis of an example labeling peptide by using an N-terminal thiourea, and an example of the labeling of a galactose-binding variant of a mannose-binding protein (gMBP). These protocols are freely adaptable for the preparation and labeling of any protein containing an N-terminal glycine, and they can be carried out with essentially any material that can be chemically conjugated to the labeling peptide.
MaterIals

REAGENTS
 crItIcal All solvents used for reactions should be of the highest quality possible. Solvents for extractions and reaction workup should be at least reagent grade. All manipulations should be carried out in a fume hood. Solid and liquid waste generated must be disposed of in accordance with the local environmental regulations.
Fmoc-amino acids (Sigma-Aldrich, VWR International or Cambridge Bioscience) 
Single-neck round-bottomed flasks, 25-500 ml Glass chromatography column, 500 ml to 1 liter, diameter >3 cm Magnetic stir bars Hot plate/magnetic stirrer Separation funnels, 500 ml to 1 liter Storage bottles, 1 liter Freezer dryer High vacuum pump Water pump Vacuum manifold Thick-walled balloon gas container connected to a two-way stopcock adapter with Luer fittings Thin-layer chromatography (TLC) plates Buchner flask, 500 ml Neutral-glass sample tube, 14 ml Gilson p200 pipette Inner diameter fritted glass funnel, 7 cm REAGENT SETUP Saturated aqueous solution of sodium chloride Weigh ~400 g of sodium chloride and add it to a 1-liter storage bottle. Fill the bottle to the 900-ml mark and shake it to dissolve the sodium chloride. As the sodium chloride dissolves, top up the bottle to the 1-liter mark. Approximately 10% of the sodium chloride will remain undissolved. Allow the solid to settle upon storage. The solution can be stored for at least 1 year at room temperature (18-25 °C) . Solution of sodium thiosulfate, 10% (wt/vol) Weigh out 100 g of sodium thiosulfate and add it to a 1-liter measuring beaker with a Teflon magnetic stirrer. Fill the measuring beaker up to the 800-ml mark and stir the solution for 2-3 min until all the solid has dissolved. Fill the beaker to the 1-liter mark with deionized water. Store the solution in a 1-liter storage bottle. The solution can be stored for several weeks at room temperature. Ligation buffer Weigh out HEPES (11.90 g), NaCl (8.70 g) and CaCl 2 (0.55 g) and add them to a 1-liter measuring beaker with a Teflon magnetic stirrer. Fill the measuring beaker up to the 800-ml mark with deionized water and stir the solution for 2-3 min until all the solid has dissolved. Adjust the pH of the solution to 7.50 by slowly adding NaOH solution (5 mM) with a pipette. Fill the beaker up to the 1-liter mark with deionized water. The ligation buffer will consist of HEPES (50 mM), CaCl 2 (5 mM) and NaCl (150 mM) at pH 7.5. Store the solution in a 1-liter storage bottle for up to 3 weeks at 4 °C. EQUIPMENT SETUP HPLC Analyze the peptides using an Agilent 1290 affinity LC system equipped with an Ascentis Express 10 cm × 2.1 mm, 2.7-µm ES-C18 peptide column (0.5 ml min −1 ) and perform UV detection at 220-280 nm. The gradient varies from 0.1% TFA/5% acetonitrile (vol/vol) in H 2 O to 0.1% TFA/95% acetonitrile in H 2 O over 5 min 40 s. High-resolution mass spectrometry Carry out protein MS analysis using a Bruker HCT Ultra MS system equipped with an Agilent 1200 series autosampler. Inject the protein directly into the instrument after dilution in 0.1% TFA/50% acetonitrile (vol/vol) in H 2 O.
•
proceDure part 1 -synthesis of the precursor: preparation of Fmoc-thr(otbu)-Gc-obn • tIMInG 19 h (overnight step) 1| Add 20 ml of THF to a 100-ml round-bottomed flask equipped with a magnetic stirrer bar. To this flask, sequentially add 10 g (25 mmol) of Fmoc-Thr(tBu)-OH, 5.9 ml (38 mmol) of benzyl 2-bromoacetate and a catalytic amount of tetrabutylammonium iodide (3.7 g, 10 mmol) before adding 5.2 ml (30 mmol) of triethylamine. Stir the reaction mixture overnight at room temperature. After a few minutes of stirring, the solution will turn yellow and a solid should be seen to precipitate.
2|
On the next day, pour the reaction mixture into a 500-ml separating funnel, wash the flask out with 200 ml of deionized H 2 O and extract the crude product with 2 × 200 ml of ethyl acetate.
3|
Combine the ethyl acetate extracts and wash them in a 1-liter separating funnel with 2 × 400 ml of 10% (wt/vol) sodium thiosulfate solution and 400 ml of saturated NaCl solution. Collect the ethyl acetate layer and add anhydrous sodium sulfate in ~3-g portions until the solid stops clumping together to ensure that the solution is dry. Filter the mixture and reduce the filtrate to dryness by rotary evaporation at 40 °C (~4.0 Torr). The residue will be a yellow oil.
purification of Fmoc-thr(otbu)-Gc-obn by chromatography • tIMInG 2 h 4| Prepare a silica gel slurry by adding 300 ml of a 4:1 mixture of hexane/ethyl acetate to ~250 g of silica gel 60 Å (40-60-µm particle size). The slurry should be added to a column with a 4.5-to 5-cm inner diameter and the column should be packed until the compressed silica layer reaches 30-35 cm in height.
5| Dissolve the crude product in a minimal volume of CH 2 Cl 2 . Apply the product to the column, and elute with a 4:1 mixture of hexane/ethyl acetate. Collect fractions of 15-20 ml and analyze by thin layer chromatography. The desired product can be visualized under a UV lamp, and it should have an R f of 0.53 in a mixture of 2:1 hexane/ethyl acetate. To speed up the elution of the product, the solvent system may be ramped up to a 1:1 mixture of hexane/ethyl acetate after the product is initially detected.
6|
Combine fractions containing the product and evaporate them to dryness by rotary evaporation at 40 °C (~4.0 Torr) to leave a slightly colored oil as the product. Dry the product to remove residual solvent by using a high vacuum line (0.1 Torr), and store it at −20 °C. The oil will form a glassy solid. Starting with 10 g of Fmoc-Thr(OtBu) will typically produce 13 g of the product.
preparation of Fmoc-thr(otbu)-Gc-oH
• tIMInG 1-6 h 7| Add 12 ml of THF to a 100-ml round-bottomed flask equipped with a magnetic stirrer bar. To this flask, add 1.0 g of Fmoc-Thr(OtBu)-Gc-OBn (1.80 mmol) and stir the solution until all the solid has dissolved before slowly adding 4 ml of H 2 O. To the stirred solution, add 100 mg of palladium on carbon (10 wt%), and seal the flask with an appropriate-sized rubber Suba-seal.
? troublesHootInG 8| Fit a two-way stopcock with Luer fittings to a thick-walled balloon and fill it with hydrogen. Attach a needle to the stopcock with the Luer fitting and insert the needle into the reaction vessel through the Suba-seal. ! cautIon Hydrogen gas is extremely flammable and should be handled with extreme care in a ventilated fume hood fitted with a blast shield. Inexperienced users must consult their safety advisor on the local rules for handling and dispensing hydrogen before attempting this part of the protocol. Additional portions of the palladium on carbon catalyst must not be added to the system under hydrogen gas as it may spontaneously ignite.
9|
Evacuate the air from the reaction vessel and purge three times with hydrogen. Stir the reaction mixture at room temperature under hydrogen for 1-6 h. Refill the balloon if necessary.
10|
Remove 5-15 µl of samples by using a needle to allow the reaction to be monitored by TLC (4:1 hexane/ethyl acetate, 1% acetic acid). The desired product should have an R f of 0.23 in this solvent mixture.  crItIcal step The hydrogenation step should be monitored carefully, and if the reaction is very close or at completion it should be stopped immediately. Allowing the hydrogenation process to take place for prolonged periods will cause cleavage of the Fmoc-protecting group, making the subsequent purification step more difficult. The Fmoc cleavage byproduct will have an R f of 0.78 in a mixture of 2:1 hexane/ethyl acetate. ? troublesHootInG 11| Once the reaction is complete, purge the reaction vessel with nitrogen and expose it to the atmosphere.
12| Pack a pad of Celite (~13 g) suspended in THF on a 7-cm inner diameter fritted glass funnel (~3 cm high). Connect the funnel to a 500-ml Büchner flask attached to a water pump. Under reduced pressure, wash the Celite pad with a mixture of 3:1 THF/H 2 O until the filtration solution is clear and free from contaminants.
13| Filter the reaction mixture through the pad of Celite and wash it twice with 100 ml of 3:1 THF/H 2 O solution.
14|
Transfer the filtrate to a 500-ml round-bottomed flask and remove the solvent under reduced pressure by using a rotary evaporator at 40 °C (~4.0 Torr). The crude product is obtained as an off-white, foamy solid. ? troublesHootInG  pause poInt If no Fmoc cleavage was detected during Steps 9 and 10, then the crude product can be used without further purification. In this case, proceed to Step 18. Trace amounts of Fmoc-Thr(OtBu)-Gc-OBn starting material do not appear to interfere with the solid-phase peptide synthesis. If Fmoc cleavage has occurred, the crude product can be stored at least 3-4 d at −20 °C before further purification is carried out.
purification of Fmoc-thr(otbu)-Gc-oH • tIMInG 2-3 h plus overnight freeze drying 15| Prepare a silica gel slurry by adding 100 ml of a 9:1 mixture of CH 2 Cl 2 /methanol to ~40 g of silica gel 60 Å (40-to 60-µm particle size). The slurry should be added to a column with a 3.5-to 4.0-cm inner diameter, and the column should be packed until the compressed silica layer reaches 18-22 cm in height. 23| Dissolve the reagents in 4 ml of DMF, and add 10 equivalents of DIPEA (203 µl, 1.10 mmol) to the solution. Mix the sample using a vortex mixer to ensure that all the compounds are dissolved. After the addition of DIPEA, the solution should turn a dark yellow/orange.
24|
Connect the reservoir to a vacuum manifold, and drain the DMF from the pre-swollen resin.
25|
Add the amino acid solution to the preswollen resin and rotate for 1 h.
26|
Once 1 h has elapsed, drain the amino acid solution from the resin using the vacuum manifold. Add 4 ml of DMF to the resin and agitate the resin by rotation for 2 min. Drain the DMF and repeat the procedure twice.
27|
Remove the Fmoc group from the resin by rotating in 4 ml of 20% (vol/vol) piperidine/DMF solution for 2 min. Drain the cleavage mixture, and repeat the procedure four more times.
28|
Wash the resin thoroughly by rotating in 6 ml of DMF for 2 min. Drain the DMF, and repeat the procedure four more times.  crItIcal step It is imperative that all the residual piperidine is removed, as it can interfere with the subsequent coupling step. 
31|
Repeat Steps 22-26 using Fmoc-Leu-OH.
32|
Repeat the coupling of Fmoc-Leu-OH by repeating Steps 22-28 to ensure maximum coupling efficiency to the slightly hindered proline residue.
33|
Wash the resin by rotating in 4 ml of DMF for 2 min. Drain the DMF and repeat this wash step twice.
34| Wash the resin further by rotating in 4 ml of CH 2 Cl 2 for 2 min. Drain the DCM and repeat this wash step twice.
35|
Shrink the resin by rotating in 6 ml of methanol for 2 min. Drain the methanol and repeat this shrinking step twice. Leave the resin to partially dry for 15 min by exposing the reservoir to reduced pressure on the vacuum manifold.
36| Place the reservoir under high vacuum (0.1 Torr) for at least 3 h to completely dry the resin.  pause poInt The reservoir containing the dry depsipeptide-loaded resin can be sealed with Parafilm and stored at −20 °C for several months.
peptide elongation • tIMInG variable 37| Swell the depsipeptide-loaded resin by adding 6 ml of DMF and rotating it for 20 min.
38|
Repeat Steps 22-28 with the desired Fmoc-protected amino acid.
n-terminal fluorescent labeling with isothiocyanates • tIMInG 20 h (overnight step) 39|
Repeat Steps 22-28 using Fmoc-GABA-OH.
40|
Weigh out 6 equivalents of FITC (219 mg, 0.66 mmol) into a 14-ml neutral-glass sample tube.
41|
Dissolve the FITC in 900 µl of DMF and add 14 equivalents of DIPEA (319 µl, 1.54 mmol).  crItIcal step It is important to dissolve the FITC in a minimal amount of solvent, as the coupling efficiency to the peptide is concentration dependent. FITC is more soluble once the DIPEA has been added, so ensure that the solution is well mixed once all reagents have been added.
42|
Add the FITC solution to the resin and rotate the mixture overnight at room temperature.  crItIcal step Completely cover the peptide reservoir in aluminum foil to protect the reaction from light.  pause poInt The FITC-peptide conjugation is left overnight.
43|
The next day, drain the FITC solution from the resin. Wash the resin thoroughly by rotating it in 6 ml of DMF for 2 min. Drain the DMF and repeat the procedure four more times.
44| Repeat Steps 34-36.
Depsipeptide cleavage • tIMInG 20 h (overnight step) 45| Prepare a 3-ml cleavage cocktail consisting of TFA:H 2 O:TIS (95:2.5:2.5) in a 14-ml neutral-glass sample tube. ! cautIon TFA is a corrosive volatile solution and should only be handled in a fume hood with suitable ventilation.
46| Transfer 2 ml of the cleavage cocktail into the dried resin, and rotate the mixture for 2 h to cleave the depsipeptide.
47|
While the depsipeptide is being cleaved, add 40 ml of ether to a Falcon tube and cool it to −20 °C.
48|
After 2 h, drain the cleavage cocktail into the pre-prepared cold ether to precipitate the depsipeptide. Store the ether suspension at −20 °C until Step 50.
49|
Transfer the remaining 1 ml of cleavage cocktail into the resin and rotate it for a further 5 min to ensure that all the depsipeptide is removed from the resin.
50|
Drain the residual cleavage cocktail into the cold ether to precipitate any remaining depsipeptide.
51| Pellet the cleaved depsipeptide by centrifuging the ether layer for 10 min at 4,000g. Centrifugation can be performed at room temperature as long as the ether has been prechilled.
52|
Decant off the ether layer and resuspend the depsipeptide pellet in 40 ml of cold ether. Mix the sample with a vortex mixer to ensure complete resuspension, and then centrifuge the suspension for 10 min at 4,000g. Centrifugation can be performed at room temperature as long as the ether has been prechilled. Repeat this step twice.
53|
Decant off the ether layer and remove any residual ether with a glass pipette. Leave the depsipeptide pellet exposed to the atmosphere for 1 h to ensure that it is almost completely free from ether.
54|
Dissolve the peptide pellet in a minimal amount of water (1-5 ml), and flash-freeze it in liquid nitrogen before freeze-drying overnight to yield a fluffy solid.
? troublesHootInG  pause poInt Confirm the peptide identity by high-resolution MS (HRMS), and confirm purity by HPLC.
part 3 -typical protein labeling procedure: preparation of stock solution • tIMInG variable  crItIcal The following concentrations are for a typical protein labeling reaction in our laboratory, but they can be varied depending on the scale of the reaction.
55|
Prepare a stock solution of 2 mM depsipeptide in ligation buffer and store it in a 1.5-ml Eppendorf tube at −20 °C.  pause poInt The depsipeptide stock solution should be stored at −20 °C, as the ester linkage is susceptible to hydrolysis.
56| Prepare a solution of 120 µM protein in ligation buffer and store it in a 1.5-ml Eppendorf tube at 4 °C.
57|
Prepare a solution of 300 µM SrtA in ligation buffer and store it in a 1.5-ml Eppendorf tube at 4 °C.  pause poInt SrtA can be stored for 2-3 weeks at 4 °C, but it can be flash-frozen and stored at −80 °C for longer periods (6 months). The enzyme still functions after several cycles of flash freezing without the addition of a cryoprotectant.
typical protein labeling procedure • tIMInG 4-6 h 58| In a clean 1.5-ml Eppendorf tube, add 50 µl of gMBP stock (60 µM), 3 µl of SrtA stock (6 µM, 0.1 mole equivalents, 6 µl of depsipeptide stock (120 µM, 2 equivalents) and 41 µl of ligation buffer.
59|
Thoroughly mix the ligation solution with a Gilson p200 pipette and incubate the tube at 37 °C.  pause poInt With larger volumes (approximately above 1 ml), it may be beneficial to agitate the ligation mixture to ensure complete mixing.
60|
Monitor the progress of the ligation reaction using SDS-PAGE, or electrospray MS. (We routinely follow protein labeling reactions in real-time using standard protein MS methods as shown in Fig. 3 ). Protein modification is typically complete in 4-6 h. However, if there is still substantial starting material remaining after 4 h, add another 1. 
61|
Once the ligation is complete, isolate the protein using a suitable affinity column. gMBP was isolated by using a lactose-agarose affinity column.  crItIcal step Leaving the ligation reaction for prolonged periods will cause SrtA to hydrolyze the label from the modified protein. The reaction mixture should either be isolated straight away or flash-frozen to stop the reaction.
? troublesHootInG Troubleshooting advice can be found in table 2.
• tIMInG Part 1 -Synthesis of the precursor If hydrolysis is a problem, then 3 equivalents of depsipeptide and 0.2 mole equivalents of SrtA can usually be used to achieve complete protein modification Poor ligation efficiency At very low protein concentrations (e.g., 10 µM), the efficiency of the ligation reaction can be greatly reduced
The use of 3-5 equivalents of depsipeptide and 0.2-0.3 mole equivalents of SrtA will usually achieve complete protein modification
